Shilpa Gupta, Director of Genitourinary Oncology at the Cleveland Clinic, shared a post on LinkedIn:
“After an incredibly productive AUA 2026, left energized by the momentum and innovation shaping bladder cancer care.
It was an honor to co-chair a GU summit, participate in the plenary crossfire debate, deliver a podium presentation, and moderate the International Bladder Cancer Group (IBCG) debate.
Beyond the science, cherished my time connecting with friends and collaborators from around the world who share a common vision of advancing care for bladder cancer patients.
From novel therapeutics and emerging biomarkers to efforts addressing unmet needs, the field is evolving rapidly and the future of multidisciplinary bladder cancer care has never looked brighter!”
Other articles about AUA 2026 on OncoDaily.
